KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Accured Expenses (2016 - 2026)

Acadia Pharmaceuticals has reported Change in Accured Expenses over the past 16 years, most recently at -$48.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 1857.32% year-over-year to -$48.0 million; the TTM value through Dec 2025 reached $1.1 million, down 62.84%, while the annual FY2025 figure was $1.1 million, 62.84% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$48.0 million at Acadia Pharmaceuticals, down from $27.8 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $54.9 million in Q3 2023 and troughed at -$48.0 million in Q4 2025.
  • A 5-year average of $5.1 million and a median of $1.7 million in 2021 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 1871.17% in 2025 and fell as far as 1857.32% in 2025.
  • Year by year, Change in Accured Expenses stood at $2.2 million in 2021, then tumbled by 811.49% to -$15.7 million in 2022, then soared by 342.41% to $38.1 million in 2023, then crashed by 92.83% to $2.7 million in 2024, then crashed by 1857.32% to -$48.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ACAD at -$48.0 million in Q4 2025, $27.8 million in Q3 2025, and $21.5 million in Q2 2025.